Lymphoplasmacytoid lymphoma

strong surface expression of the CD30 (Ki-1) antigen, a cytokine receptor in the tumor necrosis factor receptor family. The majority of ALCL demonstrate T-cell surface markers and/or clonal rearrangements of the T-cell receptor locus. There are two main clinical forms: systemic and cutaneous. The cutaneous form is particularly indolent. While it is clinically aggressive, systemic ALCL is generally sensitive to chemotherapy. Approximately 30% of those diagnosed die of the disease.

Approximately 50% of the systemic ALCL carry the t(2;5), which confers a good prognosis. Long-term survival of t(2;5)-positive patients is 80% while that of t(2;5)-negative patients is 25%. The t(2;5)(p23;q35) results in a chimeric gene encoding a fusion of the nucleophosmin (NPM) and anaplastic lymphoma kinase (ALK) proteins. NPM is a multifunctional protein which has been implicated in ribosome assembly, control of centrosome duplication, and nuclear transport as a shuttle protein; it also possesses chaperonin and ribo-nuclease activities. ALK is a member of the insulin family of receptor tyrosine kinases. Its natural ligand is unknown. The NPM-ALK fusion contains the oligomerization domain of NPM and the tyrosine kinase domain of ALK. It results in a self-oligomerizing, constitutively active tyrosine kinase with transforming properties. NPM-ALK can activate numerous downstream effectors, including phospholipase C-y phopho-inositol 3'-kinase and RAS.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment